Occudo Quantitative Strategies LP Invests $248,000 in IBEX Limited (NASDAQ:IBEX)

Occudo Quantitative Strategies LP bought a new position in shares of IBEX Limited (NASDAQ:IBEX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 11,522 shares of the company's stock, valued at approximately $248,000. Occudo Quantitative Strategies LP owned 0.07% of IBEX at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. Royce & Associates LP increased its stake in shares of IBEX by 3.7% during the fourth quarter. Royce & Associates LP now owns 548,481 shares of the company's stock worth $11,787,000 after purchasing an additional 19,481 shares during the period. Wellington Management Group LLP increased its stake in shares of IBEX by 4.6% during the fourth quarter. Wellington Management Group LLP now owns 545,175 shares of the company's stock worth $11,716,000 after purchasing an additional 23,800 shares during the period. Ameriprise Financial Inc. increased its stake in shares of IBEX by 0.9% during the fourth quarter. Ameriprise Financial Inc. now owns 510,402 shares of the company's stock worth $10,969,000 after purchasing an additional 4,777 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of IBEX by 30.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 326,141 shares of the company's stock worth $7,009,000 after purchasing an additional 76,302 shares during the period. Finally, Franklin Resources Inc. increased its stake in shares of IBEX by 18.8% during the fourth quarter. Franklin Resources Inc. now owns 296,114 shares of the company's stock worth $6,363,000 after purchasing an additional 46,849 shares during the period. Institutional investors own 81.24% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on IBEX. Royal Bank of Canada increased their target price on IBEX from $21.00 to $24.00 and gave the stock a "sector perform" rating in a research note on Friday, February 7th. Robert W. Baird downgraded IBEX from an "outperform" rating to a "neutral" rating and set a $30.00 price target on the stock. in a research report on Monday, May 12th. Finally, Baird R W downgraded IBEX from a "strong-buy" rating to a "hold" rating in a research report on Monday, May 12th.

Insider Buying and Selling

In related news, CEO Robert Thomas Dechant sold 49,931 shares of the stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $26.24, for a total transaction of $1,310,189.44. Following the sale, the chief executive officer now owns 213,633 shares of the company's stock, valued at $5,605,729.92. This represents a 18.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Bruce Neil Dawson sold 10,000 shares of the firm's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $24.48, for a total value of $244,800.00. Following the completion of the sale, the insider now directly owns 5,607 shares in the company, valued at approximately $137,259.36. This represents a 64.07% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 85,131 shares of company stock valued at $2,228,585 over the last 90 days. 6.72% of the stock is owned by corporate insiders.

IBEX Trading Up 1.0%

Shares of NASDAQ:IBEX opened at $28.59 on Friday. The company has a market capitalization of $377.16 million, a P/E ratio of 13.42 and a beta of 0.74. IBEX Limited has a 1 year low of $14.93 and a 1 year high of $32.08. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.44 and a quick ratio of 1.44. The business's 50 day simple moving average is $24.86 and its 200 day simple moving average is $22.94.

About IBEX

IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company products and services portfolio includes ibex Connect, that offers customer service, technical support, revenue generation, and other revenue generation outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that comprises digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.